EUVIMEDEUVIMED entdecken
Open Access

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis

Martilias Farrell, Tyler E Dietterich, Matthew K Harner, Lisa M Bruno, Dawn M Filmyer, Rita A Shaughnessy, Maya L Lichtenstein, Allison M Britt, Tamara F Biondi, James J Crowley, Gabriel Lázaro-Muñoz, Annika E Forsingdal und 8 weitere

Schizophrenia Bulletin · 04.07.2023 · 49 (4) · 881-892

DOI: 10.1093/schbul/sbac175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 01.12.2022. Verfasst von Martilias Farrell und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Psychotic Disorders, Schizophrenia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NHGRI NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unknown why ~30% of patients with psychotic disorders fail to respond to treatment. Previous genomic investigations of treatment-resistant psychosis have been inconclusive, but some evidence suggests a possible link between rare disease-associated copy number variants (CNVs) and worse clinical outcomes in schizophrenia. Here, we identified schizophrenia-associated CNVs in patients with treatment-resistant psychotic symptoms and then compared the prevalence of these CNVs to previously published schizophrenia cases not selected for treatment resistance.

Methods

CNVs were identified using chromosomal microarray (CMA) and whole exome sequencing (WES) in 509 patients with treatment-resistant psychosis (a lack of clinical response to ≥3 adequate antipsychotic medication trials over at least 5 years of psychiatric hospitalization). Prevalence of schizophrenia-associated CNVs in this sample was compared to that in a previously published large schizophrenia cohort study.

Results

Integrating CMA and WES data, we identified 47 cases (9.2%) with at least one CNV of known or possible neuropsychiatric risk. 4.7% (n = 24) carried a known neurodevelopmental risk CNV. The prevalence of well-replicated schizophrenia-associated CNVs was 4.1%, with duplications of the 16p11.2 and 15q11.2-q13.1 regions, and deletions of the 22q11.2 chromosomal region as the most frequent CNVs. Pairwise loci-based analysis identified duplications of 15q11.2-q13.1 to be independently associated with treatment resistance.

Conclusions

These findings suggest that CNVs may uniquely impact clinical phenotypes beyond increasing risk for schizophrenia and may potentially serve as biological entry points for studying treatment resistance. Further investigation will be necessary to elucidate the spectrum of phenotypic characteristics observed in adult psychiatric patients with disease-associated CNVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotic DisordersSchizophreniaHumansCohort StudiesDNA Copy Number VariationsPrevalenceGenetic Predisposition to Disease

Stichwörter der Autor:innen

15q11.2-q13.1 duplication16p11.2 duplicationcopy number variantsneurodevelopmental disordersrare variantsschizophreniatreatment-resistant psychosisultra-TRS

Autor:innen und Institutionen

  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Translational Neuroscience, LLC, Conshohocken, PA, USA.
  • Department of Neurology, Geisinger Health System, Wilkes Barre, PA, USA.
  • School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Office of the Vice Chancellor for Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

ORCID-Profile: Richard C Josiassen

Förderung

  • NIMH NIH HHS
  • NHGRI NIH HHS
  • NIEHS NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Farrell, M., Dietterich, T. E., Harner, M. K., Bruno, L. M., Filmyer, D. M., Shaughnessy, R. A., Lichtenstein, M. L., Britt, A. M., Biondi, T. F., Crowley, J. J., Lázaro-Muñoz, G., Forsingdal, A. E., Nielsen, J., Didriksen, M., Berg, J. S., Wen, J., Szatkiewicz, J., Mary Xavier, R., Sullivan, P. F., & Josiassen, R. C. (2023). Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis. Schizophrenia Bulletin, 49(4), 881-892. https://doi.org/10.1093/schbul/sbac175

Vancouver

Farrell M, Dietterich TE, Harner MK, Bruno LM, Filmyer DM, Shaughnessy RA, et al. Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis. Schizophrenia Bulletin. 2023;49(4):881-892. doi:10.1093/schbul/sbac175

BibTeX
@article{Farrell2023,
  author = {Farrell, Martilias and Dietterich, Tyler E and Harner, Matthew K and Bruno, Lisa M and Filmyer, Dawn M and Shaughnessy, Rita A and Lichtenstein, Maya L and Britt, Allison M and Biondi, Tamara F and Crowley, James J and Lázaro-Muñoz, Gabriel and Forsingdal, Annika E and Nielsen, Jacob and Didriksen, Michael and Berg, Jonathan S and Wen, Jia and Szatkiewicz, Jin and Mary Xavier, Rose and Sullivan, Patrick F and Josiassen, Richard C},
  title = {Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis},
  journal = {Schizophrenia Bulletin},
  year = {2023},
  volume = {49},
  number = {4},
  pages = {881--892},
  doi = {10.1093/schbul/sbac175}
}
Kostenlos starten →